Gastric Mucosal Oxidative Stress Markers in Children with Helicobacter Pylori Infection

Adel A Hagag1, Saleh M Amin1, Mohammed H Emara1

  • 1Department of Pediatrics, Faculty of Medicine, Tanta University, Tanta, Egypt, Egypt.

Insights

Helicobacter pylori infection in children causes gastric mucosal oxidative stress, indicated by lower nitric oxide and glutathione, and higher MDA, catalase, and SOD levels. Antioxidants may aid treatment.

Area of Science:

  • Pediatric Gastroenterology
  • Infectious Diseases
  • Biochemistry

Background:

  • Helicobacter pylori (H. pylori) is a common gastric pathogen.
  • H. pylori infection generates reactive oxygen and nitrogen species, contributing to oxidative stress.
  • Evaluating oxidative stress markers in H. pylori-infected children is crucial for understanding disease mechanisms.

Purpose of the Study:

  • To assess oxidative stress markers in the gastric mucosa of children infected with H. pylori.
  • To compare oxidative stress profiles between H. pylori-infected children and healthy controls.

Main Methods:

  • A study involving 60 H. pylori-infected children and 60 healthy controls (ages 7-11).
  • H. pylori infection confirmed via stool antigen testing.
  • Gastric biopsies analyzed for urease activity and oxidative stress markers: Malondialdehyde (MDA), Superoxide dismutase (SOD), reduced glutathione (GSH), Catalase, and nitric oxide (NO).

Main Results:

  • H. pylori-infected children exhibited significantly lower gastric mucosal nitric oxide and reduced glutathione compared to controls.
  • Elevated levels of Malondialdehyde (MDA), Catalase, and Superoxide dismutase (SOD) were observed in H. pylori-infected children.
  • Hematemesis was a clinical presentation exclusive to the infected group, with significant differences in abdominal pain characteristics.

Conclusions:

  • H. pylori infection is strongly associated with gastric mucosal oxidative stress in children.
  • The observed alterations in oxidative stress markers (lower NO/GSH, higher MDA/Catalase/SOD) highlight the impact of H. pylori.
  • Antioxidant therapies may serve as beneficial adjuncts for managing H. pylori infection due to its association with oxidative stress.
Abstract

Related Concept Videos

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
702
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.5K
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.3K
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
940
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.6K
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.5K